Cargando…
Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility
STUDY QUESTION: Which agent for ovarian stimulation (OS) is the most cost-effective option in terms of net benefit for couples with unexplained subfertility undergoing IUI? SUMMARY ANSWER: In settings where a live birth is valued at €3000 or less, between €3000 and €55 000 and above €55 000, clomiph...
Autores principales: | van Eekelen, R, Wang, R, Danhof, N A, Mol, F, Mochtar, M, Mol, B W, van Wely, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366296/ https://www.ncbi.nlm.nih.gov/pubmed/33615360 http://dx.doi.org/10.1093/humrep/deab013 |
Ejemplares similares
-
Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis
por: Danhof, N A, et al.
Publicado: (2020) -
Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
por: van Eekelen, R, et al.
Publicado: (2020) -
Does the effectiveness of IUI in couples with unexplained subfertility depend on their prognosis of natural conception? A replication of the H2Oil study
por: van Eekelen, R, et al.
Publicado: (2020) -
Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial
por: Wessel, J A, et al.
Publicado: (2022) -
Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials
por: Wessel, J A, et al.
Publicado: (2020)